Can the Mirena (levonorgestrel-releasing intrauterine system) coil exacerbate hormonal imbalance and symptoms in Polycystic Ovary Syndrome (PCOS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The Mirena coil is unlikely to worsen hormonal imbalance or symptoms in PCOS and may actually help manage some symptoms, as it releases a small amount of progestin hormone locally in the uterus with minimal systemic absorption. For women with PCOS, the Mirena coil can provide several benefits, including effectively managing heavy menstrual bleeding, reducing the risk of endometrial hyperplasia, and providing contraception without significantly affecting insulin resistance or androgen levels 1. The localized action of the Mirena coil means it typically doesn't exacerbate metabolic issues or worsen acne and hirsutism that many PCOS patients experience.

Some key points to consider when using the Mirena coil in PCOS patients include:

  • The Mirena coil can help manage heavy menstrual bleeding and reduce the risk of endometrial hyperplasia, which are common concerns in PCOS patients
  • The localized action of the Mirena coil means it has minimal systemic absorption, which reduces the risk of exacerbating metabolic issues or worsening acne and hirsutism
  • Some women may experience initial spotting, breast tenderness, or mood changes when first using the Mirena coil, but these usually resolve within 3-6 months
  • The Mirena coil can be used as part of an overall PCOS management plan, which may also include lifestyle modifications, metformin for insulin resistance, or other treatments specific to the patient's symptoms 1.

It's worth noting that the evidence on the use of the Mirena coil in PCOS patients is limited, and more research is needed to fully understand its effects. However, based on the available evidence, the Mirena coil appears to be a safe and effective option for managing symptoms in PCOS patients. As with any medical treatment, it's essential to discuss the potential benefits and risks with a healthcare provider to determine the best course of treatment for each individual patient.

From the Research

Hormonal Imbalance and PCOS

  • The Mirena coil, also known as the levonorgestrel-releasing intrauterine system (LNG-IUS), has been studied for its effects on hormonal imbalance and symptoms in polycystic ovary syndrome (PCOS) patients 2, 3, 4.
  • Research suggests that the LNG-IUS can reduce menstrual blood loss and increase hemoglobin levels in PCOS patients, indicating a potential benefit for managing hormonal imbalance symptoms 2.
  • However, some studies have found that the LNG-IUS may not significantly alter clinical or metabolic variables in PCOS patients, including hormone levels, over a period of 6-24 months 3, 4.

Metabolic Effects

  • The LNG-IUS has been shown to increase fasting glycemia in PCOS patients, which may be a concern for those with insulin resistance or metabolic disorders 3, 4.
  • On the other hand, the LNG-IUS has been found to reduce mean ovarian volume, LDL levels, and total cholesterol levels in PCOS patients, which may have a positive impact on metabolic health 3, 4.

PCOS Diagnosis and Treatment

  • PCOS is a complex multigenic disorder with strong epigenetic and environmental influences, and its diagnosis and treatment require a comprehensive approach 5.
  • The LNG-IUS may be a useful treatment option for PCOS patients with simple endometrial hyperplasia, as it has been shown to increase clinical pregnancy rates and implantation rates in these patients 6.

Conclusion is not allowed, therefore the response will be ended here.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Levonorgestrel-releasing intrauterine system effects on metabolic variables in PCOS.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2023

Related Questions

Can the Mirena (levonorgestrel) intrauterine device with low-dose estrogen exacerbate hormonal imbalance and symptoms in Polycystic Ovary Syndrome (PCOS) in a 30-year-old woman?
What is the most appropriate therapy for a patient with Polycystic Ovarian Syndrome (PCOS) and endometrial hyperplasia with mild atypia, presenting with irregular menses and infertility?
What blood work is recommended for the diagnosis and management of Polycystic Ovary Syndrome (PCOS)?
What bloodwork is recommended for the diagnosis and management of Polycystic Ovary Syndrome (PCOS)?
What is the best approach to manage a patient with Polycystic Ovary Syndrome (PCOS) who has anti-SSB (Anti-Sjögren's Syndrome B) antibodies and joint pain?
What causes intraocular vitreous hemorrhage (vitreous haematoma)?
Are antibiotics administered in acute appendicitis?
What is the next treatment option for a patient with impaired glucose regulation who is intolerant to metformin (Metformin) and cannot afford Ozempic (Semaglutide)?
Can the Mirena (levonorgestrel) intrauterine device with low-dose estrogen exacerbate hormonal imbalance and symptoms in Polycystic Ovary Syndrome (PCOS) in a 30-year-old woman?
What is the approach to managing urethritis in the emergency department and what questions should be asked during the clinical interview?
Can the Mirena (levonorgestrel-releasing intrauterine system) coil with low-dose estrogen exacerbate hormonal imbalance and symptoms in Polycystic Ovary Syndrome (PCOS) in a 30-year-old woman with elevated estrogen levels, previously on Evorel (estradiol) 25?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.